上海莱士

002252 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

40.0B ($5.8B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

8.2B

Net Income

2.2B

Gross Margin

N/A

Op. Margin

32.8%

Net Margin

26.8%

ROE

6.9%

ROA

6.5%

D/E

0.05

Dividend Yield

N/A

EPS

0.33

Current Ratio

5.60

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human serum albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human thrombin and human fibrin adhesive, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. The company was founded in 1988 and is based in Shanghai, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 上海莱士

Ticker	002252
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业